Skip to main content
Screener/Healthcare/Biotechnology

XFOR — X4 Pharmaceuticals, Inc.

NASDAQ
$4.20+0.13 (+3.19%)
Penny StockUnder $5Healthcare
$1.35
$4.83
$4.05
$4.24
EPS (TTM)$-4.34
P/E Ratio-5.75
Dividend Yield—
Market Cap$48.0M
Volume200K
Prev Close$4.07
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$2.6M-$23.9M$-0.2266.4%-931.7%
Q3 '25$1.8M-$29.8M$-0.6980.1%-1689.2%
Q2 '25$2.0M-$25.7M$-3.4783.5%-1304.7%
Q1 '25$28.8M$282K$0.0483.6%1.0%
Q4 '24$1.4M-$39.8M$-6.0078.9%-2776.9%
Q3 '24$560K-$36.7M$-5.4845.2%-6552.9%
Q2 '24$563K$90.8M$13.5717.9%16133.7%
Q1 '24$0-$51.8M$-7.77——
Get Your Daily Market Recap